Bdmards for the treatment of severe active rheumatoid athritis – December 2009

PBAC Review of bDMARDs for the treatment of severe active rheumatoid athritis

  • Brand names:
    • Multiple brands
  • Pharmaceutical Company:
    • Bristol-Myers Squibb Australia Pty Ltd
    • PharmaLink Pty Ltd
    • Abbott Australasia Pty Ltd
    • Wyeth Australia Pty Ltd
    • Schering-Plough Pty Ltd
    • Roche Products Pty Ltd
  • Condition/Indication:
  • Meeting Date: December 2009
  • Public Summary Document (PSD) December 2009 PBAC Meeting - PDF
Last updated
19 February 2010